Navigation Links
Tumors grow faster without blood-supply promoting molecule
Date:11/10/2008

Dense networks of blood vessels thought to spur cancer's growth could actually hinder rather than promote tumor progression, according to a new study at the University of California, San Diego.

The findings partly explain why drugs designed to treat cancer by strangling its blood supply have been disappointing when used alone and why those treatments are more effective when combined with traditional chemotherapy.

Despite their rapid progression, tumors fed by more normal vascular were also more vulnerable to the effects of standard chemotherapy drugs, the team reports in this week's early online edition of the journal Nature.

Nascent tumors take off as new blood vessels invade, an event called angiogenesis that many see as key to the development of malignancy. But those pathological vessels form tangled structures that are far from normal.

"Tumor blood vessels become more chaotic, disorganized and leaky," said Randall S. Johnson, professor of molecular biology at UC San Diego who led the study. "They become dysfunctional in many ways as a blood vessel network."

Cellular secretions within tumors promote the invasion. The first drugs designed to curtail cancer's blood supply targeted one of these, called VEGF for vascular endothelial growth factor. Inflammatory cells, which infiltrate many types of tumors, provide one source of VEGF.

Johnson's team created a strain of mice in which most inflammatory cells were missing the gene for VEGF, then cross-bred them with a strain that reliably develops mammary tumors and is commonly used to study breast cancer.

"The blood vessels look more organized and less leaky in the engineered mice," said Christian Stockmann, a molecular biology postdoctoral fellow and the first author of the paper.

The blood supply to tumors in these mice was also sparse compared to mice with intact VEGF genes.

"A lot of these classic hallmarks of tumor blood vessels disappeared when the inflammatory cells couldn't make VEGF," Johnson said.

But the cancer grew faster.

All of the mice developed tumors, but at 20 weeks of age, those with low levels of VEGF from inflammatory cells had larger growths that were more likely to have progressed to a later stage of cancer.

"The tumors seemed much happier when they didn't have this chaotic vasculature," Johnson said.

The scientists also injected a cancerous cell line into normal and engineered mice and found that the introduced cells invaded normal tissues more readily without VEGF from inflammatory cells and developed more normal blood supplies.

The tumors that formed were also more susceptible to two different chemotherapy drugs in the mice lacking VEGF from inflammatory cells.

By identifying the cellular source of the critical factor for one pathology associated with cancer, the researchers say their findings may open new avenues for treatment.


'/>"/>

Contact: Randall Johnson
rsjohnson@ucsd.edu
858-822-0509
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis
2. Chemo Alone Effective in Treating Kids Brain Tumors
3. Breast Cancer Vaccine Blasts Some Tumors
4. Nanomedical approach targets multiple cancer genes, shrinks tumors more effectively
5. Drug Re-Sensitizes Breast Tumors to Treatment
6. Drug/radiation combo may help shrink established tumors
7. Leading Neurosurgical Center in Moscow Purchases CyberKnife System to Expand Ability to Treat Brain and Spinal Tumors
8. Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study
9. Researchers hone technique to KO pediatric brain tumors
10. Researchers identify promising cancer drug target in prostate tumors
11. Identification of 5 genes involved in the metastasis of breast tumors to the lung
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 23, 2017 , ... OSF Ventures, the corporate ... largest start-up platform headquartered in Silicon Valley that connects startups to corporations and ... signed a three-year agreement to be a corporate sponsor of Plug and Play’s ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... from 140 Buzzies users who entered metrics into the product’s app. The ... The new data showed that within just 30 seconds of using Buzzies, people ...
(Date:1/23/2017)... ... 2017 , ... A Northwestern Pennsylvania addiction treatment center unveiled ... Rehabilitation & Recovery Center’s new website can be found at AlpineSpringsRehab.com . ... and retooled website. The treatment center has also revamped its social media strategy, ...
(Date:1/23/2017)... ... 2017 , ... DMG Productions is proud to announce the ... to broadcast Saturday, January 28, 2017 at 5:00pmEST. , This segment will educate ... the limitations of fatigue monitoring technologies within the mining industry. Today SmartCap is ...
(Date:1/23/2017)... OR (PRWEB) , ... January 23, 2017 , ... Sharon ... to the air to educate listeners about the benefits of making new water infrastructure ... U.S.,” Kleyne said, “it’s appropriate that we expect water infrastructure to become a top ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... YORK , January 24, 2017 ... Ltd (NASDAQ: GENE ), Alder Biopharmaceuticals Inc. (NASDAQ: ... BDSI ), and Egalet Corp. (NASDAQ: EGLT ... was moderately lower on Monday, January 23 rd , 2017, ... shares of health care companies in the S&P 500 also ...
(Date:1/24/2017)... 2017 INTRODUCTION Injectable drug delivery systems ... with vials to prefilled syringes, auto-injectors, pen injectors ... become preferred devices for parenteral administration of drugs. ... rising strongly over the past several years. A ... this format for delivering drugs. The popularity of ...
(Date:1/24/2017)... LONDON , Jan. 23, 2017 The ... revenue in 2015, and it is expected to grow ... peripheral I.V. catheter segment accounted for larger share in ... whereas, among the various end users, the hospital segment ... during the same year. The global peripheral I.V. catheter ...
Breaking Medicine Technology: